Universitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2016

  1. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 6, pp. 471-478

2015

  1. Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

    AIDS, Vol. 29, Núm. 5, pp. 571-581

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2010

  1. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study

    The Lancet, Vol. 376, Núm. 9738, pp. 340-345

2008

  1. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

    HIV Medicine, Vol. 9, Núm. 2, pp. 82-88

2005

  1. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

    Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28

1992

  1. Multifocal tubercular osteitis in a female patient infected with the human immunodeficiency virus

    Revista clínica española, Vol. 191, Núm. 1, pp. 35-37

1991

  1. Abdominal tuberculosis in patients with acquired immunodeficiency syndrome

    Medicina clínica, Vol. 97, Núm. 4, pp. 121-124

  2. Non-Parenteral Transmission of Hepatitis C Virus

    International Journal of STD and AIDS

1990

  1. Diagnosis of human retrovirus infections by techniques of nucleic acid amplification/hybridization

    Medicina clínica, Vol. 95, Núm. 7, pp. 262-264

  2. El virus de la inmunodeficiencia humana tipo II (VIH-2).

    Revista clinica espanola, Vol. 186, Núm. 8, pp. 394-399

  3. El virus humano linfotrópico T de tipo 1 (HTLV-I).

    Medicina clinica, Vol. 94, Núm. 4, pp. 143-148

  4. Investigación del HTLV-I en pacientes de Barcelona con conectivopatías, enfermedades neurológicas desmielinizantes y síndromes linfoproliferativos.

    Medicina clinica, Vol. 94, Núm. 19, pp. 730-732

  5. Primoinfección por el virus de la inmunodeficiencia humana: aspectos clínicos y serológicos de 7 casos.

    Medicina clinica, Vol. 94, Núm. 12, pp. 441-443

  6. Risk factors for HIV-1 infection in parenteral drug users

    AIDS

  7. Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain

    The Lancet

  8. Synthetic Peptide Immunoassay in Diagnosis of Primary HIV Infection

    Vox Sanguinis

  9. The evaluation of heterosexual transmission of the human immunodeficiency virus by nucleic acid amplification technics

    Medicina clínica, Vol. 95, Núm. 14, pp. 535-537

1989

  1. Human immunodeficiency virus type 2 in Spain

    European Journal of Clinical Microbiology & Infectious Diseases